Reduced phagocytosis of apoptotic cells in malignant lymphoma

International Journal of Cancer

Volumn 75, Issue 5, 1998, Pages 675-679

  Hermann, Michael ^a,b   Niemitz, Carsten ^b   Marafioti, Teresa ^c   Schriever, Folke ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MACROPHAGE; MAJOR CLINICAL STUDY; MANTLE CELL LYMPHOMA; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0032473582     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980302)75:5<675::AID-IJC26>3.0.CO;2-5     Document Type: Article

References (30)

1. BEHR, S. and SCHRIEVER, F., Engaging CD19 or target of an amiproliferative antibody 1 on human B lymphocytes induces binding of B cells to the interfollicular stroma of human tonsils via integrin alpha 4/beta 1 and fibronectin. J exp. Med., 182, 1191-1199 (1995).
2. BENOMAR, A., GERLIER, D. and DORE, J.F., In vivo activation of nude mouse macrophages by human melanoma cells. J. nat. Cancer Inst., 79, 131-136 (1987).
3. COHEN, J.J., DUKE, R.C., FADOK, V.A. and SELLINS, K.S., Apoptosis and programmed cell death in immunity. Ann. Rev. Immunol., 10, 267-293 (1992).
4. EVANS, R., DUFFY, T. and CULLEN, R.T., Tumor-associated macrophages stimulate the proliferation of murine tumor cells surviving treatment with the oncolytic cyclophosphamide analogue Asta Z-7557: in vivo implications. Int. J. Cancer, 34, 883-890 (1984).
5. FADOK, V.A., SAVILL, J.S., HASLETT, C., BRATTON, D.L., DOHERTY, D.E., CAMPBELL, P.A. and HENSON, P.M., Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol., 149, 4029-4035 (1992).
6. FLORA, P.K. and GREGORY, C.D., Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur. J. Immunol., 24, 2625-2632 (1994).
7. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol., 119, 493-501 (1992).
8. GORCZYCA, W., GONG, J. and DARZYNKIEWICZ, Z., Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res., 53, 1945-1951 (1993).
9. HARRIS, N.L. and 18 OTHERS, A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood, 84, 1361-1392 (1994).
10. HERMANN, M., SCHOLMAN, H.J., MARAFTOTI, T., STEIN, H. and SCHRIEVER, F., Differential expression of apoptosis, Bcl-x and c-Myc in normal and in malignant lymphoid tissues. Europ. J. Haematol., 59, 20-30 (1997).
11. JOACHIM, H.L., Non-Hodgkin lymphoma. In: H.L. Joachim (ed.), Lymph node pathology, pp. 337-431, Lippincott, Philadelphia (1994).
12. KADHIM, S.A. and REES, R.C., Enhancement of tumor growth in mice: evidence for the involvement of host macrophages. Cell. Immunol., 87, 259-269 (1984).
13. KERR, J.F.R., WYLLIE, A.M. and CURRIE, A.R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer, 26, 239-257 (1972).
14. KISSELEVA, E., BECKER, M., LEMM, M. and FICHTNER, I., Involvement of macrophages and cytokines into rejection mechanism of the drug-resistant and immunonenic murine lymphoma P388/adria. Anticancer Res., 16, 1971-1978 (1996).
15. LE, P.T., MAECKER, H.T. and COOK, J.E., In situ detection and characterization of apoptotic thymocytes in human thymus. Expression of bcl-2 in vivo does not prevent apoptosis. J. Immunol., 154, 4371-4378 (1995).
16. LECHLEITNER, M., GATTRINGER, C., GASTL, G., RADASKIEWICZ, T., PRALLER, W., SCHMALZL, F. and HUBER, H., Macrophage infiltration in non-Hodgkin's lymphomas: a quantitative in situ study. Immunobiology, 171, 381-387 (1986).
17. LEONCINI, L., DEL VECHHIO, M.T., MEGHA, T., BARBINI, P., GALIENI, P., PILERI, S., SABATTINI, E., GHERLINZONI, F., TOSI, P., KRAFT, R. and COTTIER, H., Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Amer. J. Palhol., 142, 755-763 (1993).
18. LEONCINI, L., DEL VECCHIO, M.T., SPINA, D., MEGHA, T., BARBINI, P., SABATTINI, E., PILERI, S., TOSI, P., KRAFT, R., LAISSUE, J.A. and COTTIER, H., Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int. J. Cancer, 61, 826-831 (1995).
19. MURO CACHO, C.A., PANTALEO, G. and FAUCI, A.S., Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol., 154, 5555-5566 (1995).
20. SAVILL, J., DRANSFIELD, I., HOGG, N. and HASLETT, C., Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature (Lond.), 343, 170-173 (1990).
21. SAVILL, J., FADOK, V., HENSON, P. and HASLETT, C., Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14, 131-136 (1993).
22. SCHRIEVER, F. FREEDMAN, A.S., FREEMAN, G., MESSNER, E., LEE, G., DALEY, J. and NADLER, L.M., Isolated human follicular dendritic cells display a unique antigenic phenotype. J. exp. Med., 169, 2043-2058 (1989).
23. SEARLE, J., LAWSON, T.A., ABBOTT, P.J., HARMON, B. and KERR, J.F., An electron-microscope study of the mode of cell death induced by cancer-chemotherapeutic agents in populations of proliferating normal and neoplastic cells. J Pathol., 116, 129-138 (1975).
24. SPINA, D., LEONCINI, L., DEL VECCHIO, M.T., MEGHA, T., MINACCI, C., POGGI, S.A., PILERI, S., TOSI, P., KRAFT, R., LAISSUE, J.A. and COTTIER, H., Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J. Pathol., 177, 335-341 (1995).
25. SPINA, D., LEONCINI, L., MEGHA, T., DEL VECCHIO, M.T., MINACCI, C., POGGI, S., PILERI, S., TOSI, P., KRAFT, R., LAISSUE, J.A. and COTTIER, H., Stage-related differences of mitotic and apoptotic indices, and bcl-2 protein expression in diffusely growing non-Hodgkin's lymphomas. Int. J. Cancer, 68, 436-440 (1996).
26. STANSFELD, A.C., and 14 OTHERS, Updated Kiel classification for lymphomas [letter] [published erratum appears in Lancet, 372, 8581, 1988]. Lancet, 1, 292-293 (1988).
27. SURH, C.D. and SPRENT, J., T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature (Lond.), 372, 100-103 (1994).
28. UEDA, N. and SHAH, S.V., Apoptosis. J. Lab. clin. Med., 124, 169-177 (1994).
29. VERHOVEN, B., SCHLEGEL, R.A. and WILLIAMSON, P., Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J exp. Med., 182, 1597-1601 (1995).
30. WYLLIE, A.H., Apoptosis. Brit. J. Cancer, 67, 205-208 (1993).